Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants

BACKGROUND: Direct oral anticoagulants (DOACs) may increase the risk of gastrointestinal (GI) bleeding in patients with atrial fibrillation (AF) and GI cancer compared with vitamin K antagonists (VKA). METHODS: We conducted a Danish nationwide cohort study comparing the bleeding risk associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ording, Anne Gulbech, Søgaard, Mette, Skjøth, Flemming, Grove, Erik Lerkevang, Lip, Gregory Y. H., Larsen, Torben Bjerregaard, Nielsen, Peter Brønnum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267127/
https://www.ncbi.nlm.nih.gov/pubmed/34114733
http://dx.doi.org/10.1002/cam4.4012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267127/
https://www.ncbi.nlm.nih.gov/pubmed/34114733
http://dx.doi.org/10.1002/cam4.4012

Ejemplares similares